We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SYNH
651
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-3,342,622
Closed -$141M –
ICNC
652
DELISTED
Iconic Sports Acquisition Corp.
ICNC
– –
-462,203
Closed -$4.92M –
RETA
653
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-16,000
Closed -$133K –
RETA
654
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-5,000
Closed -$510K –
GFGD
655
DELISTED
The Growth for Good Acquisition Corporation Class A Ordinary Shares
GFGD
– –
-453,158
Closed -$4.73M –
DBTX
656
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
– –
-199,200
Closed -$767K –
CHEAW
657
DELISTED
Chenghe Acquisition Co. Warrant
CHEAW
– –
-222,541
Closed -$12.4K –
MBSC
658
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
– –
-369,763
Closed -$3.86M –
UTAA
659
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
– –
-498,474
Closed -$5.27M –
PIAI
660
DELISTED
Prime Impact Acquisition I
PIAI
– –
-437,286
Closed -$4.67M –
BKI
661
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-16,329
Closed -$975K –
NUVA
662
DELISTED
NuVasive, Inc.
NUVA
– –
-941,845
Closed -$39.2M –
FOCS
663
DELISTED
Focus Financial Partners Inc. Class A
FOCS
– –
-2,775,549
Closed -$146M –
FGMC
664
DELISTED
FG Merger Corp. Common Stock
FGMC
– –
-222,542
Closed -$2.35M –
ZING
665
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
– –
-503,225
Closed -$5.25M –
ARNC
666
DELISTED
Arconic Corporation
ARNC
– –
-112,720
Closed -$3.33M –
APMI icon
667
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
– –
-231,102
Closed -$2.38M –
AFTR.WS
668
DELISTED
AfterNext HealthTech Acquisition Corp Warrants
AFTR.WS
– –
-678,553
Closed -$59.6K –
AFTR
669
DELISTED
AfterNext HealthTech Acquisition Corp
AFTR
– –
-1,395,656
Closed -$14.5M –
CPAA
670
DELISTED
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
– –
-2,867,097
Closed -$29.3M –
CPAAW
671
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
– –
-979,817
Closed -$44.1K –
DICE icon
672
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-1,075,000
Closed -$49.9M –
PDCE
673
DELISTED
PDC Energy, Inc.
PDCE
– –
-3,101,445
Closed -$221M –
ARBGW
674
DELISTED
Aequi Acquisition Corp warrants
ARBGW
– –
-153,405
Closed -$4.68K –
UNVR
675
DELISTED
Univar Solutions Inc.
UNVR
– –
-6,121,961
Closed -$219M –

Similar funds

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.